topmenu
Wyniki wyszukiwania:
wyszukanych pozycji: 27
 |
Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphia, Pa October 4 and
ISBN: 9781461296263 / Angielski / Miękka / 2011 / 356 str. Termin realizacji zamówienia: ok. 20 dni roboczych. In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model...
In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon...
|
cena:
586,33 zł |
 |
Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15-16, 1987, Philadelphia, Pennsylvania
ISBN: 9781461289807 / Angielski / Miękka / 2012 / 242 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina sufferers in the United states have frequent episodes of silent myocardial ischemia. Although it is not possible to define how many Americans die due to silent ischemia, it has been suggested that the mortality rate may exceed hundreds of thousands of victims annually. Unfortunately, there still...
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two d...
|
cena:
586,33 zł |
 |
Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphia, Pa October 4 and
ISBN: 9780898387162 / Angielski / Twarda / 1985 / 356 str. Termin realizacji zamówienia: ok. 20 dni roboczych. In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model...
In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon...
|
cena:
586,33 zł |
 |
Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15-16, 1987, Philadelphia, Pennsylvania
ISBN: 9780898383805 / Angielski / Twarda / 1988 / 242 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina sufferers in the United states have frequent episodes of silent myocardial ischemia. Although it is not possible to define how many Americans die due to silent ischemia, it has been suggested that the mortality rate may exceed hundreds of thousands of victims annually. Unfortunately, there still...
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two d...
|
cena:
586,33 zł |
 |
Congestive Heart Failure: Proceedings of the Symposium on New Drugs and Devices October 30-31, 1986, Philadelphia, Pennsylvania
ISBN: 9780898389555 / Angielski / Twarda / 1987 / 290 str. Termin realizacji zamówienia: ok. 20 dni roboczych. About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend...
About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart fai...
|
cena:
859,97 zł |
 |
Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi
ISBN: 9781461338789 / Angielski / Miękka / 2011 / 302 str. Termin realizacji zamówienia: ok. 20 dni roboczych. In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of...
In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Card...
|
cena:
586,33 zł |
 |
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on
ISBN: 9781461288886 / Angielski / Miękka / 2011 / 298 str. Termin realizacji zamówienia: ok. 20 dni roboczych. The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents. The use of thrombolytic agents has become one of the major advances in clinical intensive cardiologic care in the 1980s. While the lysis of...
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and member...
|
cena:
781,79 zł |
 |
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
ISBN: 9780792307563 / Angielski / Twarda / 1990 / 230 str. Termin realizacji zamówienia: ok. 20 dni roboczych. The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman...
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and rel...
|
cena:
586,33 zł |
 |
The Evaluation of New Antiarrhythmic Drugs: Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhy
ISBN: 9789400982727 / Angielski / Miękka / 2011 / 340 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Thus, there are now several chronic canine myocardial infarction- ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same localized reentrant mechanism that characterizes chronic human myocardial infarction and chronic coronary 26 artery disease. However, these models are not suitable for determining whether a new drug...
Thus, there are now several chronic canine myocardial infarction- ventricular tachyarrhythmia models which are available for the evaluation of new ant...
|
cena:
195,42 zł |
 |
Congestive Heart Failure: Proceedings of the Symposium on New Drugs and Devices October 30-31, 1986, Philadelphia, Pennsylvania
ISBN: 9781461292326 / Angielski / Miękka / 2011 / 290 str. Termin realizacji zamówienia: ok. 20 dni roboczych. About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend...
About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart fai...
|
cena:
859,97 zł |
 |
Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi
ISBN: 9780898385809 / Angielski / Twarda / 1983 / 302 str. Termin realizacji zamówienia: ok. 20 dni roboczych. In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of...
In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Card...
|
cena:
586,33 zł |
 |
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on
ISBN: 9780792302940 / Angielski / Twarda / 1989 / 298 str. Termin realizacji zamówienia: ok. 20 dni roboczych. The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents. The use of thrombolytic agents has become one of the major advances in clinical intensive cardiologic care in the 1980s. While the lysis of...
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and member...
|
cena:
781,79 zł |
 |
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
ISBN: 9781461288091 / Angielski / Miękka / 2011 / 230 str. Termin realizacji zamówienia: ok. 20 dni roboczych. The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman...
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and rel...
|
cena:
586,33 zł |
 |
Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development
ISBN: 9781617376122 / Angielski / Miękka / 2010 / 362 str. Termin realizacji zamówienia: ok. 20 dni roboczych. It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important is to define its safety when administered to millions of patients with multi-faceted d- eases, co-morbidities, sensitivities and concomitant medi- tions. The commonest cause of new drug discontinuations, cause for disapproval from marketing and removal from the market after approval is a drug s effect on cardiac repolari- tion which is essentially identified by increasing the duration of the QTc interval duration on the standard 12-lead elect-...
It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important i...
|
cena:
586,33 zł |
 |
Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development
ISBN: 9781588295156 / Angielski / Twarda / 2004 / 362 str. Termin realizacji zamówienia: ok. 20 dni roboczych. It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important is to define its safety when administered to millions of patients with multi-faceted d- eases, co-morbidities, sensitivities and concomitant medi- tions. The commonest cause of new drug discontinuations, cause for disapproval from marketing and removal from the market after approval is a drug's effect on cardiac repolari- tion which is essentially identified by increasing the duration of the QTc interval duration on the standard 12-lead elect-...
It is generally easy to define the efficacy of a new the- peutic agent. However, what is even more difficult and more challenging yet more important i...
|
cena:
586,33 zł |
 |
American Eldercide: How It Happened, How to Prevent It
ISBN: 9780226827766 / Angielski Termin realizacji zamówienia: ok. 13-18 dni roboczych. |
cena:
132,62 zł |
 |
The Art and Craft of Teaching
ISBN: 9780674046801 / Angielski / Miękka / 1984 / 144 str. Termin realizacji zamówienia: ok. 30 dni roboczych. Good teaching does not come naturally or easily to anyone, even to those who seem to have a gift for it. This concise and lively guide developed from the faculty seminars of the Harvard-Danforth Center for Teaching and Learning contains hundreds of insights into the fine and difficult art of leading students to demand more of themselves, find new ways of solving problems, and awaken unsuspected talents. Filled with useful suggestions for improving teaching skills, The Art and Craft of Teaching offers solutions to problems that every instructor faces and suggests strategies that will enrich...
Good teaching does not come naturally or easily to anyone, even to those who seem to have a gift for it. This concise and lively guide developed from ...
|
cena:
149,13 zł |
 |
The Big Move: Life Between the Turning Points
ISBN: 9780253020642 / Angielski / Miękka / 2016 / 118 str. Termin realizacji zamówienia: ok. 22 dni roboczych. When her husband's ill health forces them to move into an assisted living facility, Anne M. Wyatt-Brown suddenly finds herself surrounded by elderly residents. In this lively and provocative collection, other distinguished gerontologists reflect on Anne's moving account of her transition to becoming a member of a vibrant and sociable community that offers care-giving support, while encouraging her to pursue her own interests, including exercising, reviewing articles for scholarly journals, serving on committees, and singing. By redefining notions of care and community, undoing the stigmas... When her husband's ill health forces them to move into an assisted living facility, Anne M. Wyatt-Brown suddenly finds herself surrounded by elderl... |
cena:
77,42 zł |
 |
Aged by Culture
ISBN: 9780226310626 / Angielski / Miękka / 2004 / 232 str. Termin realizacji zamówienia: ok. 22 dni roboczych. In this work, Margaret Morganroth Gullette reveals that ageing doesn't start in our chromosomes, but in midlife downsizing, the erosion of workplace seniority, threats to social security, and greedy Baby Boomers.
In this work, Margaret Morganroth Gullette reveals that ageing doesn't start in our chromosomes, but in midlife downsizing, the erosion of workplace s...
|
cena:
132,80 zł |
 |
Ending Ageism, or How Not to Shoot Old People
ISBN: 9780813589282 / Angielski / Miękka / 2017 / 294 str. Termin realizacji zamówienia: ok. 22 dni roboczych. When the term "ageism" was coined in 1969, many problems of exclusion seemed resolved by government programs like Social Security and Medicare. As people live longer lives, today's great demotions of older people cut deeper into their self-worth and human relations, beyond the reach of law or public policy. In Ending Ageism, or How Not to Shoot Old People, award-winning writer and cultural critic Margaret Morganroth Gullette confronts the offenders: the ways people aging past midlife are portrayed in the media, by adult offspring; the esthetics and politics of representation in...
When the term "ageism" was coined in 1969, many problems of exclusion seemed resolved by government programs like Social Security and Medicare. As peo...
|
cena:
147,14 zł |
Czytaj nas na:
Zobacz: Księgarnia Czeska | Wydawnictwo Książkowe Klimaty | Mapa strony | Lista autorów
KrainaKsiazek.PL - Księgarnia Internetowa
KrainaKsiazek.PL - Księgarnia Internetowa
